The chair at Virginia Commonwealth University’s Department of Chemical and Life Science Engineering will deliver the Dreyfus Lecture, sponsored by Kalamazoo College’s Department of Chemistry and Biochemistry, this Thursday.
B. Frank Gupton—whose research group is focused on the development of continuous processing technology to facilitate the discovery, development and commercialization of drug products—will discuss public access to essential medicines in a post-pandemic environment. He is the founder of VCU’s Medicines for All institute, which focuses on improving global access to lifesaving medicines.
Before joining VCU, Gupton’s 30-year industrial career centered on the development and commercialization of chemical processes for pharmaceutical applications. That time included years he served as the executive director of North American process development for Boehringer Ingelheim Pharmaceuticals, where he led the commercialization of the HIV drug nevirapine.
In 2018, Gupton received the American Chemical Society Award for Affordable Green Chemistry and the Presidential Award for Green Chemistry. In 2019, he earned the Peter J. Dunn Award for Green Chemistry and Engineering Impact in the Pharmaceutical Industry from the ACS Green Chemistry Institute Pharmaceutical Round Table. Gupton holds a bachelor’s degree in chemistry from the University of Richmond and graduate degrees in organic chemistry from Georgia Tech and VCU.
The public is invited to the lecture, which will begin at 6:30 p.m. in the Dalton Theatre. For more information, contact the chemistry and biochemistry department at 269.337.7007.